Buscar en
Progresos de Obstetricia y Ginecología
Toda la web
Inicio Progresos de Obstetricia y Ginecología Tratamiento quirúrgico del cáncer de vulva: vulvectomía radical frente a vulv...
Información de la revista
Vol. 45. Núm. 6.
Páginas 238-244 (Enero 2002)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 45. Núm. 6.
Páginas 238-244 (Enero 2002)
Acceso a texto completo
Tratamiento quirúrgico del cáncer de vulva: vulvectomía radical frente a vulvectomía radical modificada
Surgical management of vulvar cancer: radical vulvectomy versus modified radical vulvectomy
Visitas
22859
C. Salvador Ballada
Autor para correspondencia
csalvador@eniac.es

Correspondencia: Hospital San Millán. Autonomía de la Rioja, 3. 26004 Logroño
, A. Alejos Monzón, M.J. Iñarra Velasco, E. Esteban Campeny, G. Manzanera Bueno
Este artículo ha recibido
Información del artículo
Resumen
Objetivo

Valorar las complicaciones postoperatorias tempranas y tardías según la técnica quirúrgica en el tratamiento del cáncer vulvar así como las recurrencias y la supervivencia

Sujetos y métodos

Se estudian 44 casos de cáncer vulvar habidos en nuestro medio desde 1981 a 1999. De éstos se diferencian 2 grupos según las técnicas más empleadas: grupo I, de 1981-1989 (n = 14), en el que se realizó vulvectomía radical (VR) en alas de mariposa y grupo II, de 1989-1999 (n = 10), en el que se practicó vulvectomía radical modificada (VRM) con incisiones separadas

Resultados

Las complicaciones más frecuentes a corto plazo son: la dehiscencia de la cicatriz e infección de la herida, que inciden en la VR en el 57 y el 21,4%, respectivamente, frente al 40 y el 10% en la VRM. Esto conduce a que la estancia media hospitalaria se reduzca en las pacientes a las que se realizó VRM de forma estadísticamente significativa (34,6 días en VR frente a 19,8 días en VRM). A largo plazo, el linfedema y la disfunción sexual aparecen en el 43,8 y el 57% de casos de VR, respectivamente, frente al 20 y el 40% de casos de VRM

Las diferencias halladas en las variables cualitativas valoradas con el test de Fisher no resultaron significativas, pero sí la encontradas en la cuantitativa de estancia media hospitalaria calculada por el método de Mann-Whitney. Respecto a las recidivas precoces y tardías, así como la supervivencia a los 5 años, tampoco modifican los resultados según la técnica empleada. La supervivencia en estadio I con la VR es del 87,5% y en la VRM del 83%

Conclusiones

Se puede ser más conservador en la técnica quirúrgica mejorando la morbilidad postoperatoria sin modificar los resultados, teniendo en cuenta que el mayor éxito se consigue en estadios precoces y sin afectación ganglionar inguinal, que son los factores pronósticos más relevantes

Palabras clave:
Tratamiento quirúrgico del cáncer de vulva
Abstract
Objective

To compare early and late postoperative complications recurrence and survival according to the surgical technique used in the treatment of vulvar carcinoma

Subjects and methods

We studied 44 patients with vulvar carcinoma who were treated in our center between 1981 and 1999. The patients were divided into two groups according to the techniques most commonly used. Group 1 consisted of 14 patients who underwent radical vulvectomy (RV) with the Taussig-Way operation between 1981-1989. Group II consisted of 10 patients who underwent modified radical vulvectomy (MRV) using the three-incision approach between 1989–1999

Results

The most frequent early complications were groin wound breakdown and infection which occurred in 57% and 21.4% of patients who underwent RV versus 40% and 10% of those who underwent MRV. Consequently, mean hospital stay was significanatly reduced in patients who underwent MRV (34.6 days in RV versus 19.8 days in MRV). Major late complications were lymphedema and sexual disfunction which occurred in 43.8% and 57% of patients who underwent RV versus 20% and 40% of those who underwent MRV

No significant differences were found in the qualitative variables evaluated with Fisher's test but significant differences (p<0.001) were found in the quantitative variable of hospital mean stay calculated by the Mann-Whitney test. No diferences were found in early and late recurrences or in 5-year survival according to the surgical procedure used. Survival in patients with stage I tumors who underwent RV was 87.5% and was 83% in those who underwent MRV

Conclusions

Conservative surgery improves postoperative morbidity without modifying outcome. The most important prognostic factors for a favorable outcome are early stage disease and absende of groin node metastases

keywords:
Surgical management
Vulvar carcinoma
El Texto completo está disponible en PDF
Bibliografía
[1.]
L.M. Puig-Tintoré, J. González Merlo.
Oncología ginecológica. Neoplasia intraepitelial y cáncer de vulva, pp. 25
[2.]
M.A. Morgan, J.J. Mikuta.
Surgical management of vulvar cancer.
Semin Surg Oncol, 17 (1999), pp. 168-172
[3.]
A. Ansink.
Vulvar squamous cell carcinoma.
Semin Dermatol, 15 (1996), pp. 51-59
[4.]
J.M. Salmeán.
Monografías en cirugía ginecológica. Histerectomía vaginal. Vulvectomía radical: descripción de la intervención, pp. 89
[5.]
A. Onnis, M. Marchetti, T. Maggino.
Carcinoma of the vulva: critical analysis of survival ant treatment of recurrences.
Eur J Gynaecol Oncol, 13 (1992), pp. 480-485
[6.]
J.Y. Lin, B. DuBeshter, C. Angel, P.M. Dvoretsky.
Morbidity and recurrence with modifications of radical vulvectomy and groin dissection.
Gynecol Oncol, 47 (1992), pp. 80-86
[7.]
S. Kehoe, D. Luesley, K.K. Chan.
A pilot study on early postoperative morbidity and technique of inguinal node dissection in vulvarl carcinoma.
Eur J Gynaecol Oncol, 19 (1998), pp. 374-376
[8.]
J. Menczer.
A trend toward more conservative surgery in gynecologic oncology.
Obstet Gynecol Surv, 51 (1996), pp. 628-636
[9.]
C. Levenback, M. Morris, T.W. Burke, D.M. Gershenson, J.K. Wolf, J.T. Wharton.
Groin dissection practices among gynecologic oncologists treating early vulvar cancer.
Gynecol Oncol, 62 (1996), pp. 73-77
[10.]
J.A. De Hullu, H. Hollema, D.A. Piers, R.H. Verheijen, P.J. Van Diest, M.J. Mourits, et al.
Sentinel limph node procedure is highly accurate in squamous cell carcinoma of the vulva.
J Clin Oncol, 18 (2000), pp. 2811-2816
[11.]
M.S. Hoffman, W.S. Roberts, J.P. Lapolla, D. Cavanagh.
Recent modifications in the treatment of invasive squamous cell carcinoma of the vulva.
Obstet Gynecol Surv, 44 (1989), pp. 227-233
[12.]
F.B. Stehman, B.N. Bundy, P.M. Dvoretsky, W.T. Creasman.
Early stage I carcinoma of the vulva treated with ipsilateral superficial lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncologic Group.
Obstet Gynecol, 79 (1992), pp. 490-497
[13.]
M. Moscarini, G. Carta, L. Di Paolantonio, F. Patacchiola, G. Porzio, L. Di Stefano.
Surgical treatment of invasive carcinoma of the vulva. Our experience.
Eur J Gynaecol Oncol, 21 (2000), pp. 393-395
[14.]
Annual Report on the results of treatment in gynecological cancer n.° 23, (1998),
[15.]
W.T. Creasman, J.l. Phillipis, H.R. Menck.
The National cancer data base report on early stage invasive vulvar carcinoma.
Cancer, 80 (1997), pp. 505-513
[16.]
H.D. Homesley.
Management of vulvar cancer.
Cancer, 76 (1995), pp. 2159-2170
[17.]
B. Smyczek-Gargya, B. Volz, M. Geppert, J. Dietl.
A multivariate analysis of clinical and morphological prognostic factors in squamous cell carcinoma of the vulva.
Gynecol Obstet Invest, 43 (1997), pp. 261-267
[18.]
J.V. Bokhman, S.J. Maximov, A.D. Ebert.
Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases.
Zentralbl Gynakol, 119 (1997), pp. 188-272
[19.]
F. Landoni, M. Proserpio, A. Maneo, G. Cormio, G. Zanetta, R. Milani.
Repair of the perineal defect after radical vulvar surgery: direct closure versus skin flaps reconstruction. A retrospective comparative study.
Aust N Z J Obstet Gynaecol, 35 (1995), pp. 300-304
[20.]
F. Carramaschi, M.L. Ramos, A.C. Nisida, M.C. Ferreira, J.A. Pinotti.
V-Y flap for perineal reconstruction following modified approach to vulvectomy in vulvar cancer.
Int J Gynaecol Osbtet, 65 (1999), pp. 157-163
[21.]
L.Y. Huang, H. Lin, Y.T. Liu, C.C. ChangChien, S.Y. Chang.
Anterolateral thigh vastus lateralis myocutaneous flap for vulvar reconstruction after radical vulvectomy: a preliminary experience.
Gynecol Oncol, 78 (2000), pp. 391-393
[22.]
N.F. Hacker, R.S. Leuchter, J.S. Berek, T.W. Castaldo, L.D. Lagasse.
Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions.
Obstet Gynecol, 58 (1981), pp. 574-579
[23.]
G.M. Flanelly, M.E. Foley, P.M. Lenehan, P. Kelehan, J.F. Murphy, J. Stronge.
En bloc radical vulvectomy and limphadenectomy with modifications of separate groin incisions.
Obstet Gynecol, 79 (1992), pp. 307-309
[24.]
W. Christopherson, H.J. Buchsbaum, R. Voet, S. Lifschitz.
Radical vulvectomy and bilateral groin lymphadenectomy utilizing separate groin incisions: report of a case with recurrenece in the intervening skin bridge.
Gynecol Oncol, 21 (1985), pp. 247-251
[25.]
S.C. Ballon, E.J. Lamb.
Separate inguinal incisions in the treatment of carcinoma of the vulva.
Surg Gynecol Obstet, 140 (1975), pp. 81-84
[26.]
A. Leminen, M. Forss, J. Paavonen.
Wound complications in patients with carcinoma of the vulva. Comparison between radical and modified vulvectomies.
Eur J Obstet Gynecol Reprod Biol, 93 (2000), pp. 193-197
[27.]
J.F. Magriña, J. González-Bosquet, A.L. Weaver, T.A. Gaffey, M.J. Webb, K.C. Podratz, et al.
Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery.
Gynecol Oncol, 7 (1998), pp. 116-121
[28.]
A. Rodolakis, E. Diakomanolis, Z. Voulgaris, T. Akrivos, G. Vlachos, S. Michalas.
Squamous vulvar cancer: a clinically based individualization of treatment.
Gynecol Oncol, 78 (2000), pp. 346-351
[29.]
R. Farias-Eisner, F.D. Cirisano, D. Grouse, R.S. Leuchter, B.Y. Karlan, L.D. Lagasse, et al.
Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2 N0-1 M0) disease.
Gynecol Oncol, 53 (1994), pp. 55-58
[30.]
P.J. Di Saia Danforth.
Tratado de obstetricia y ginecología.
8.a ed, pp. 837
Copyright © 2002. Sociedad Española de Ginecología y Obstetricia
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos